MedKoo Cat#: 125832 | Name: SEQ-9

Description:

WARNING: This product is for research use only, not for human or veterinary use.

SEQ-9 is an oral Mtb 23S bacterial ribosome inhibitor.

Chemical Structure

SEQ-9
CAS#N/A

Theoretical Analysis

MedKoo Cat#: 125832

Name: SEQ-9

CAS#: N/A

Chemical Formula: C60H100N4O20S

Exact Mass: 1228.6700

Molecular Weight: 1229.53

Elemental Analysis: C, 58.61; H, 8.20; N, 4.56; O, 26.02; S, 2.61

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
SEQ-9; HY-153222; CS-0655585; SEQ9; SEQ 9
IUPAC/Chemical Name
(2S,3R,4R,5R,7S,9S,10S,11R,12S,13R)-2-((R)-1-(((2S,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)ethyl)-10-(((2S,3R,6R,Z)-3-hydroxy-4-(methoxyimino)-6-methyltetrahydro-2H-pyran-2-yl)oxy)-3,5,7,9,11,13-hexamethyl-7-(((2-methyl-1-(phenylsulfonamido)propan-2-yl)carbamoyl)oxy)-6,14-dioxo-12-(((2S,5R,7R)-2,4,5-trimethyl-1,4-oxazepan-7-yl)oxy)oxacyclotetradecan-4-yl 3-methylbutanoate
InChi Key
JCUPFQUUARRICQ-DXXMFXFBSA-N
InChi Code
InChI=1S/C60H100N4O20S/c1-31(2)25-44(65)80-49-37(8)51(41(12)79-57-53(74-18)52(73-17)46(66)40(11)78-57)82-55(69)39(10)50(81-45-26-33(4)64(16)29-35(6)76-45)36(7)48(83-56-47(67)43(63-75-19)27-34(5)77-56)32(3)28-60(15,54(68)38(49)9)84-58(70)62-59(13,14)30-61-85(71,72)42-23-21-20-22-24-42/h20-24,31-41,45-53,56-57,61,66-67H,25-30H2,1-19H3,(H,62,70)/b63-43-/t32-,33+,34+,35-,36+,37+,38+,39+,40+,41+,45-,46+,47+,48-,49+,50-,51-,52+,53+,56-,57-,60-/m0/s1
SMILES Code
CC(C)CC(O[C@@H]([C@@H](C)C([C@@](C)(OC(NC(C)(C)CNS(=O)(C1=CC=CC=C1)=O)=O)C[C@H](C)[C@H](O[C@@H]([C@@H]/2O)O[C@H](C)CC2=N\OC)[C@@H](C)[C@H](O[C@H]3C[C@@H](C)N(C)C[C@H](C)O3)[C@H]4C)=O)[C@@H](C)[C@@H]([C@H](O[C@@H]5O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]5OC)C)OC4=O)=O
Appearance
To be determined
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 -4 C for short term (days to weeks) or -20 C for long term(months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 1,229.53 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Zhang J, Lair C, Roubert C, Amaning K, Barrio MB, Benedetti Y, Cui Z, Xing Z, Li X, Franzblau SG, Baurin N, Bordon-Pallier F, Cantalloube C, Sans S, Silve S, Blanc I, Fraisse L, Rak A, Jenner LB, Yusupova G, Yusupov M, Zhang J, Kaneko T, Yang TJ, Fotouhi N, Nuermberger E, Tyagi S, Betoudji F, Upton A, Sacchettini JC, Lagrange S. Discovery of natural-product-derived sequanamycins as potent oral anti-tuberculosis agents. Cell. 2023 Mar 2;186(5):1013-1025.e24. doi: 10.1016/j.cell.2023.01.043. Epub 2023 Feb 23. PMID: 36827973; PMCID: PMC9994261.